Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
PVLA
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -24.6%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
qtorin
palvella
therapeutics
rapamycin
2026
phase
results
offering
malformations
rare
clinical
trial
million
announces
upsized
public
plans
pitavastatin
skin
therapies
PVLA
Palvella Therapeutics, Inc. Common Stock
StonvexStonvexStonvexStonvex